3rd Quarter - Report
W STRATEGIES, LLC for GLAXOSMITHKLINE
Firm
Client
Income
$40,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R.3433: Over-the-Counter Monograph Safety, Innovation and Reform Act. Proposed legislation around FDA cosmetics reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Medicare/Medicaid MMM
Regulatory and legislative proposals in the Administrations Blueprint. H.R.3: Lower Drug Costs Now Act of 2019. S.2543: Prescription Drug Pricing Reduction Act of 2019.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Taxation/Internal Revenue Code TAX
S.1089: Restoring Access to Medication Act of 2019.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.